Health workers and the elderly will be given priority for the vaccine.

The Australian government has purchased tens of millions of doses of four different vaccines.

But the Federal Government will not make the vaccination mandatory.

A researcher in a laboratory at the Jenner Institute in Oxford, England, works on the coronavirus vaccine developed by AstraZeneca and Oxford University. (AP)

“All Australians who seek it will be given access to a free vaccine over the course of 2021,” Mr Hunt said.

“We’re covered for the Australian population, and we have enough to vaccinate the Australian population three times over.”

The government is now considering whether to make a vaccine mandatory for people coming in from overseas.

“We would expect people coming to Australia to be vaccinated or to isolate,” Mr Hunt said.

Yesterday Qantas announced it was considering requiring passengers to be vaccinated in order to travel aboard their international flights.

A researcher in a laboratory at the Jenner Institute in Oxford, England, works on the coronavirus vaccine developed by AstraZeneca and Oxford University. (AP)

Mr Hunt would not comment on Qantas’ plans.

Thirty million doses of the AstraZeneca vaccine developed in the UK will be manufactured in Australia.

Another 3.8 million doses are scheduled for delivery from overseas.

“We’re closer than ever to a vaccine, and we’ll be able to vaccinate every Australian that wants to be vaccinated,” Health Minister Greg Hunt said.

“We’ll have a variety of options and we’re on the track to deliver the latest vaccines in March.”

The AstraZeneca vaccine will offer Australia a “pathway to a return to normal”, Health Minister Greg Hunt has said.

The vaccine developed in the United Kingdom in conjunction with Oxford University, has been shown to be effective in at least 70 per cent of cases.

“The news overnight from the United Kingdom is very good for Australians,” Mr Hunt said.

“It’s very good for the world.”

A vial of the coronavirus vaccine developed by AstraZeneca and Oxford University, in Oxford, England. (AP)

Results showed individuals who were given a half dose of the Oxford vaccine followed by a full dose a month later showed an efficacy rate of 90 per cent.

Though, when individuals were given two full doses a month apart, the vaccine had an effective rate of 62 per cent.

The vaccine was developed by Oxford University and pharmaceutical company AstraZeneca and is one of three known treatments being trialled during the pandemic.

The fresh claims about the Oxford vaccine’s abilities comes two months after it was put on hold after a participant in a UK trial suffered an adverse reaction.

The Oxford trial is one of two candidates in a $1.7 billion deal signed by the Federal Government to roll out COVID-19 vaccines to Australians next year.

A volunteer receives an injection at the Chris Hani Baragwanath hospital in Soweto, Johannesburg, as part of Africa’s first participation in a COVID-19 vaccine trial developed at the University of Oxford in Britain in conjunction with the pharmaceutical company AstraZeneca. (AP)

The Oxford vaccine includes people 70 years and older, which naturally increases the risk of temporally associated with adverse results.

The study, by Monash University’s Department of Immunology and Pathology and Alfred Research Alliance, uncovered a memory B cell which “remembers” the virus and triggers the production of protective antibodies if re-exposed.

Source link